All systems go for FP7

"It's a great day", EU Science and Research Commissioner Janez Potocnik told journalists immediately after the European Parliament approved amendments to the Seventh Framework Programme (FP7) proposal that were drafted together with the Council.

Although the new text still requires formal approval by the Competitiveness Council, this is expected to be achieved without problems at its next meeting on 4 and 5 December. This will then enable the Commission to publish the first calls for proposals on 22 December as planned, and officially launch the biggest ever European research programme.

FP7 is divided into four specific programmes. The 'Cooperation' programme will support research cooperation in a number of specified thematic areas. 'Ideas' will fund investigator-driven research through a newly created European Research Council (ERC). The 'People' programme will support training and researchers' career development, while 'Capacities' will support the coordination and development of research infrastructure, regional research clusters, international cooperation and closer ties between science and society.

The programme's budget of €54.582 billion at current prices is a 'major improvement' according to Mr Potocnik. Of this, €50.521 billion will go to the European Community programme, and €2.751 billion to the Euratom programme (fusion energy research, and fission and radiation protection), which runs from 2007 until 2011. A further €1.31 billion is foreseen for Euratom for 2012 and 2013.

The final changes to FP7 correspond to the Parliament's priorities. Amendments submitted by rapporteur and Polish MEP Jerzy Buzek ensure that children's health, respiratory diseases, neglected diseases and fisheries will receive funding; attempt to ease the participation of small and medium sized enterprises (SMEs); and give increased emphasis to the scientific training role of the Joint Research Centre (JRC).

MEPs ensured that renewable energy research will be a priority by insisting that the 'major part' of the energy budget will go to renewables and end-use efficiency, with clean coal technologies and capture and storage receiving what is left.

"This sentence can only mean one thing: that the two sets of technologies will receive over half of the budget for non-nuclear research, meaning at least €1,175 million over the seven years of FP7," said Didier Mayer, President of the European Renewable Energy Research Centres (EUREC). This figure represents an increase in real terms of around 40% compared to the average amount spent on these technologies under FP6, EUREC has calculated.

The amendments also adjust the budget slightly, with three of the four FP7 pillars (Cooperation, Ideas and People) increasing their funding envelopes slightly, and the fourth, Capacities, seeing a decrease.

There is also a change to the budget of the planned Risk Sharing Finance Facility (RSFF). The feature is intended to facilitate access to European Investment Bank (EIB) finance, allowing the funding of riskier research projects and leveraging more private funding in the process.

On the ERC, MEPs defended their request to have a mid-term review - something that the Commission was originally against - and also included an amendment to make sure that, should the structure of the Council need to be modified, it will be done in conjunction with the Parliament through the co-decision procedure. A further change increases slightly the money available for the ERC's administrative costs, from the 3% on which MEPs had previously insisted, to 5%.

Jerzy Buzek praised the quality of the original Commission proposal, saying that the parliament had changed a few things, but not the ideal behind the programme or its structure. Of 2,000 amendments from MEPs, 700 had been put to the vote, and those adopted improve the programme, he said.

Both Mr Buzek and Mr Potocnik praised the inter-institutional collaboration that made agreement possible. Mr Buzek also thanked his fellow parliamentarians for putting aside political preferences in the name of getting FP7 up and running. "I hope that this will be a principal for future discussions in the Parliament," he said.

One may be inclined to think that with the launch of FP7 now imminent, those that designed it will be looking forward to a well earned break. Messrs Potocnik and Buzek were far from giving this impression on 30 November.

According to Mr Buzek, "We haven't finished yet. The work starts today." The next step is to implement the programme, he said. And then, "We have to convince national governments, policy-makers, researchers, society that this is a good programme. We have to breathe new life into European research."

For Janez Potocnik, FP7 has undoubtedly been his biggest project since his appointment as Science and Research Commissioner in 2004. The programme may now be all but implemented, but that does not mean that his work is done. "This is a non-stop, constant journey," he said.

The Commissioner's focus is now longer term. He told journalists on 30 November to look out for a new debate on the European Research Area (ERA) in 2007. Then in 2009 there will be a debate on the financial perspectives of the European Union. 'This will be connected with the debate on the future of Europe. We have to be prepared,' he said, prepared to illustrate to policy-makers exactly how important investment in research is for Europe's competitiveness.

For further information on FP7, please visit:
http://cordis.europa.eu/fp7

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Clanwilliam Brings Epic Care to the UK

Care homes looking to digitise their administration and care procedures have a new option with the launch of Epic Care in the UK. Epic Care is a modular, scalable system developed...

AI Language Models Write Good Doctor…

Generative AI should be able to write usable doctor's letters and thus potentially speed up medical documentation, according to a study by the University Medical Center Freiburg. Around 93% of...

West Yorkshire and Harrogate Hospitals S…

Clinicians working at five of the six trusts in the West Yorkshire Association of Acute Trusts (WYAAT) can access test results from across their pathology network, following a summer roll-out...

ChatGPT Shows Human-Level Assessment of …

As artificial intelligence advances, its uses and capabilities in real-world applications continue to reach new heights that may even surpass human expertise. In the field of radiology, where a correct...

When Detecting Depression, the Eyes have…

It has been estimated that nearly 300 million people, or about 4% of the global population, are afflicted by some form of depression. But detecting it can be difficult, particularly...

When it comes to Emergency Care, ChatGPT…

If ChatGPT were cut loose in the Emergency Department, it might suggest unneeded x-rays and antibiotics for some patients and admit others who didn't require hospital treatment, a new study...

HWL 2024 Brings Together a Record Number…

1 - 2 October 2024, Luxembourg. The second edition of Healthcare Week Luxembourg on 1 and 2 October 2024, organised by the Federation of Luxembourg Hospitals (FHL), in partnership with the...

AI Drives Development of Cancer Fighting…

University of Houston researchers and their students are developing a new software technology, based on artificial intelligence, for advancing cell-based immunotherapy to treat cancer and other diseases. CellChorus...

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

Revolutionizing Cardiovascular Risk Asse…

A recent position paper in the Asia-Pacific Journal of Ophthalmology explores the transformative potential of artificial intelligence (AI) in ophthalmology. Led by Lama Al-Aswad, Professor of Ophthalmology and Irene Heinz...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Why the NHS Needs a Transparency Revolut…

Opinion Article by Dr Mark Ratnarajah, NHS paediatrician and UK Managing Director for C2-Ai. Wes Streeting wanted 'no stone left unturned' when he asked Lord Darzi to examine the current state...